Rhythm Pharmaceuticals Inc.
RYTM | NASDAQ
$105.02
-$5.66 (-5.11%)
At close: Nov 5, 2026, 4:00 PM ET
$105.00
-$0.02 (-0.02%)
After-hours:
Nov 5, 2026, 7:30 PM ET
Market Data
Market Cap $7.23B
Enterprise Value $6.91B
Beta 2.14
Average Volume 683.64K
Shares Outstanding (Diluted) 69.05M
Shares Change YoY 7.3%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US76243J1051
Price Performance
Price Change 1M 15.7%
Price Change 3M -6.3%
Price Change 6M 9.1%
Price Change YTD -1.9%
Price Change 1Y 6.6%
Price Change 3Y 287.7%
Price Change 5Y 655.5%
1M CAGR (ann.) -5.5%
1Y CAGR (ann.) -16.4%
5Y CAGR (ann.) 52.9%
All-Time CAGR 13.3%
Valuation
PE Ratio -36.21
Forward PE 2,084.70
PEG Ratio -4.66
Forward PEG 4.14
PS Ratio 25.76
Forward PS 12.70
PB Ratio 35.88
P/FCF Ratio -86.87
P/Adj. FCF Ratio -40.92
P/OCF Ratio -89.00
EV/Sales 24.62
EV/EBIT -39.73
EV/EBITDA -39.91
EV/FCF -83.05
Earnings Yield -2.8%
FCF Yield -1.1%
Adj. FCF Yield -2.4%
Financial Health
Net Cash $320.94M
Total Debt $3.52M
Cash & Short-Term Investments $320.94M
Total Assets $443.13M
Current Ratio 2.78
Quick Ratio 2.57
Debt / Equity Ratio 0.02
Debt / EBITDA -0.02
Debt / FCF -0.04
OCF / Debt -23.27
Interest Coverage -10.27
Altman Z-Score 14.26
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 88.2%
Operating Profit Margin -66.7%
EBITDA Margin -61.7%
Net Profit Margin -69.0%
FCF Margin -29.6%
Adj. FCF Margin -62.9%
SBC / Revenue 33.3%
SBC Impact (per share) -112.3%
Returns
Return on Assets -43.7%
Return on Equity -83.7%
Return on Invested Capital -63.9%
Return on Capital Employed -64.1%
Return on Tangible Assets -45.5%
Historical Growth (CAGR)
Revenue CAGR 3Y 65.5%
Revenue CAGR 5Y 191.4%
Revenue CAGR 10Y 42.2%
EPS CAGR 3Y 20.3%
EPS CAGR 5Y 4.6%
EPS CAGR 10Y -5.2%
FCF CAGR 3Y 34.1%
FCF CAGR 5Y 17.2%
FCF CAGR 10Y -6.7%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 13
EPS Growth Next 3Y 102.3%
Revenue Growth Next 3Y 65.5%
Earnings Date Feb 25, 2027
EPS Estimate (next Q) -$0.63
EPS Growth Est (next Q) -13.7%
Revenue Est (next Q) $109.59M
Revenue Growth Est (next Q) 91.4%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $144.43
Price Target Upside 37.5%
Cash Flow
Operating Cash Flow $-81.79M
Free Cash Flow $-83.24M
Adj. Free Cash Flow $-176.69M
FCF Per Share -$1.21
OCF Per Share -$1.18
OCF/S Ratio -29.1%
Income Statement
Revenue $280.75M
Gross Profit $247.69M
Operating Income $-187.25M
EBITDA $-173.24M
Net Income $-193.81M
EPS (Diluted) -$2.90
Revenue / Employee $678.14K
Profit / Employee $-468.14K
Employees 414
Add to Watchlist
Select watchlists to add or remove RYTM